Biotech Values

[genisi]

Merck said it aims to file in 2009 for regulatory approval of Rolofylline, a treatment for heart failure

Looks like Merck will not file the NDA in 2009:

Rolofylline Did Not Demonstrate Efficacy for Acute Heart Failure in Clinical Trial

http://www.merck.com/newsroom/press_releases/research_and_development/2009_0605.html